GERD Drugs and Devices Market Emerging Trends, Share, Development Strategy and Growth by 2027

 Breaking News
  • No posts were found

GERD Drugs and Devices Market Emerging Trends, Share, Development Strategy and Growth by 2027

March 03
19:55 2021
The growing demand for OTC and generic drugs and the rise in the geriatric population will drive the GERD drugs and devices market.

GERD Drugs and Devices Market

The Global GERD Drugs and Devices Market Report has been recently formulated and added by Emergen Research, which aims to provide insightful data to the readers to help them make informed business decisions. The report further focuses on the segmentation of the GERD Drugs and Devices industry based on its segments and sub-segments as well as a detailed regional analysis. The GERD Drugs and Devices market is expected to register a high CAGR of 2.3% to reach a valuation of USD 6.14 Billion by the end of 2027. The key factors and elements contributing to the growth of the industry have been thoroughly studied in the report.

The market for Gastroesophageal Reflux Disease drugs and devices is expected to grow due to an increase in the incidences of acidic taste in the mouth, heartburn, dry cough, hoarseness, and asthma, among others. GERD drugs and devices consist of various medications, devise, and surgery.

Get a sample of the report @

The report covers in-depth profiling of the prominent players of the industry and includes Johnson & Johnson, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Pfizer Inc., Novartis AG, GlaxoSmithKline Plc, Merck & CO., Inc., Boston Scientific Corporation, Eisai Co., Ltd., and Ironwood Pharmaceuticals, Inc., among others. Furthermore, it offers a detailed analysis of the competitive landscape of the market with massive data on recent trends, technological developments, product advancements, methodologies, and strategic business decisions such as mergers and acquisitions, joint ventures, collaborations, and product launches, among others.

For the purpose of this report, Emergen Research has segmented into the global GERD Drugs and Devices Market on the basis of route of administration, drug type, and device type:

  • Route Of Administration Outlook (Revenue, USD Billion; 2017-2027)
    • Oral
    • Parenteral
  • Drug Type Outlook (Revenue, USD Billion; 2017-2027)
    • H2 Receptor Antagonist
    • Proton Pump Inhibitor (PPIs)
    • Antacids
  • Device Type Outlook (Revenue, USD Billion; 2017-2027)
    • MUSE –Medigus Ultrasonic Surgical Endostapler
    • LINX Management System
    • Stretta Therapy
    • Bravo Reflux Testing System
    • Digitrapper reflux testing system
    • Others

The report further covers extensive regional analysis of the GERD Drugs and Devices industry with regards to market scope, market size, market share, revenue generation, production and consumption ratio, supply and demand ratio, and analysis of the key players operating in those regions. The regional analysis covers North America, Europe, AsiaPacific, Latin America, and Middle East & Africa.

Request a discount on the report @

Key questions answered in the Report:

  • What are the key driving factors of the GERD Drugs and Devices industry?
  • Which segment and sub-segment are expected to show significant growth during the forecast period?
  • What will the market size and growth rate be throughout the forecast period?
  • Who are the prominent players of the GERD Drugs and Devices industry?
  • What are the technological advancements and product developments taking place in the GERD Drugs and Devices market?
  • Which region is expected to dominate the market in the coming years?
  • What are the key outcomes of the SWOT analysis and Porter’s Five Forces analysis?
  • What are the key risk factors and challenges the companies will face in the market?
  • What factors are expected to hinder the growth of the GERD Drugs and Devices industry?

The report studies dynamic market elements such as drivers, restraints, challenges, threats, opportunities, and growth prospects, among others. The report presents the statistical data in an organized format with pictorial representations in charts, graphs, tables, figures, and diagrams. The report offers strategic recommendations to the new entrants as well as established players to assist them in capitalizing on the advantageous opportunities. The detailed analysis of the competitive landscape offers a competitive advantage to the reader and helps them gain a better understanding of the industry.

To read more about the report, visit @

Table of Content
Chapter 1. Methodology & Sources
    1.1. Market Definition
    1.2. Research Scope 
    1.3. Methodology
    1.4. Research Sources
          1.4.1. Primary
          1.4.2. Secondary
          1.4.3. Paid Sources
    1.5. Market Estimation Technique
Chapter 2. Executive Summary
    2.1. Summary Snapshot, 2019-2027
Chapter 3. Key Insights
Chapter 4. GERD Drugs and Devices Market Segmentation & Impact Analysis
    4.1. GERD Drugs and Devices Market Material Segmentation Analysis
    4.2. Industrial Outlook
          4.2.1. Market indicators analysis
          4.2.2. Market drivers analysis
           Increasing occurrence of GERD disorders
           Growing trend of self-medication
           Changes in lifestyle
          4.2.3. Market restraints analysis
           Low level of investment
    4.3. Technological Insights
    4.4. Regulatory Framework
    4.5. Porter’s Five Forces Analysis
    4.6. Competitive Metric Space Analysis
    4.7. Price trend Analysis
    4.8. Covid-19 Impact Analysis

Chapter 5. GERD Drugs and Devices Market By Route of Administration Insights & Trends Revenue (USD Million)  
    5.1. Route of Administration Dynamics & Market Share, 2019 & 2027
          5.1.1. Oral
          5.1.2. Parenteral

Chapter 6. GERD Drugs and Devices Market By Drug Type Insights & Trends Revenue (USD Million)  
    6.1. Drug Type Dynamics & Market Share, 2019 & 2027
          6.1.1. H2 Receptor Antagonist
          6.1.2. Proton Pump Inhibitor (PPIs)
          6.1.3. Antacids

Chapter 7. GERD Drugs and Devices Market By Device Type Insights & Trends Revenue (USD Million)  
    7.1. Device Type Dynamics & Market Share, 2019 & 2027
          7.1.1. MUSE –Medigus Ultrasonic Surgical Endostapler
          7.1.2. LINX Management System
          7.1.3. Stretta Therapy
          7.1.4. Bravo Reflux Testing System
          7.1.5. Digitrapper reflux testing system
          7.1.6. Others


Take a Look at our Related Reports:

Surgical Instrument Tracking Systems Market Size

Medical Lighting Technologies Market Share

Smart Irrigation Controllers Market Trends

Soldier System Market Growth

Plant-Based Food & Beverage Alternatives Market Analysis

Nano Drones Market Business Opportunities

Fermented Food and Ingredients Market Key Players

Mobile Robot Market Demand

Forensic Technology Market Competitive Landscape

Autonomous Delivery Vehicles Market Segments

Solid Waste Management Market Overview

Prenatal Testing Industry

Digital Biomarkers Market Statistics

Activated Carbon Market Development Strategy

Cardiac Monitoring & Cardiac Rhythm Management Devices Market Future Growth

Neurostimulation Devices Market Research Methodology

Signal Intelligence (SIGINT) Market Drivers

Sodium Dichromate Market Manufacturers

Industrial Microbiology Market Revenue

Media Contact
Company Name: Emergen Research
Contact Person: Eric Lee
Email: Send Email
Phone: +1 (604) 757-9756
Address:14671 110 Avenue Surrey, British Columbia, V3R2A9
City: Surrey
State: British Columbia
Country: Canada

Related Articles